# Active Surveillance vs Adjuvant Chemoradiotherapy for Locally Resected Intermediate-Risk T1 Rectal Cancer

> **NCT07669298** · NA · RECRUITING · sponsor: **Medical University of Gdansk** · enrollment: 480 (estimated)

## Conditions studied

- Rectal Cancer

## Interventions

- **OTHER:** Active surveillance
- **RADIATION:** Adjuvant chemoradiotherapy

## Key facts

- **NCT ID:** NCT07669298
- **Lead sponsor:** Medical University of Gdansk
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-14
- **Primary completion:** 2037-06
- **Final completion:** 2037-06
- **Target enrollment:** 480 (ESTIMATED)
- **Last updated:** 2026-06-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07669298

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07669298, "Active Surveillance vs Adjuvant Chemoradiotherapy for Locally Resected Intermediate-Risk T1 Rectal Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07669298. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*